AmyloiDia Sweden AB
Developing single-molecule sensitive blood tests for pre-symptomatic Alzheimer's diagnosis.
Översikt
- 0
- Anställda
- 100–149t SEK
- Omsättning
- 2019
- Grundat
Nyckelbeslutsfattare
Dr Vladana Vukojević
CEO
Dr Sebastian Wärmländer
Member of the Steering Board
Dr Astrid Gräslund
Chair of the Steering Board
Dr Jüri Jarvet
Member of the Steering Board
+7 fler kontakter i Funnelfeedr
Beskrivning
AmyloiDia is an R&D-driven BioMedTech company dedicated to eradicating Alzheimer’s disease through early diagnosis. Their core mission involves translating advanced quantitative analytical methods into clinical healthcare applications. They have invented a novel, minimally invasive blood-based techn...